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Abstract
The placenta plays a central role in determining the outcome of pregnancy. It undergoes changes during gestation as the
fetus develops and as demands for energy substrate transfer and gas exchange increase. The molecular mechanisms that
coordinate these changes have yet to be fully elucidated. The study performed a large scale screen of the transcriptome of
the rat placenta throughout mid-late gestation (E14.25–E20) with emphasis on characterizing gestational age associated
changes in the expression of genes invoved in angiogenic pathways. Sprague Dawley dams were sacrificed at E14.25,
E15.25, E17.25 and E20 (n = 6 per group) and RNA was isolated from one placenta per dam. Changes in placental gene
expression were identifed using Illumina Rat Ref-12 Expression BeadChip Microarrays. Differentially expressed genes (.2-
fold change, ,1% false discovery rate, FDR) were functionally categorised by gene ontology pathway analysis. A subset of
differentially expressed genes identified by microarrays were confirmed using Real-Time qPCR. The expression of thirty one
genes involved in the angiogenic pathway was shown to change over time, using microarray analysis (22 genes displayed
increased and 9 gene decreased expression). Five genes (4 up regulated: Cd36, Mmp14, Rhob and Angpt4 and 1 down
regulated: Foxm1) involved in angiogenesis and blood vessel morphogenesis were subjected to further validation. qPCR
confirmed late gestational increased expression of Cd36, Mmp14, Rhob and Angpt4 and a decrease in expression of Foxm1
before labour onset (P,0.0001). The observed acute, pre-labour changes in the expression of the 31 genes during gestation
warrant further investigation to elucidate their role in pregnancy.
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Introduction
A successful outcome to pregnancy depends on establishing an
effective materno-fetal exchange interface. Two processes critical
for materno-fetal exchange are adequate perfusion of the placenta
by maternal blood, and formation of the placental villous tree (the
exchange surface of the placenta) and its vascular network. Failure
to achieve either of these processes is associated with adverse
pregnancy outcome, including: miscarriage; intrauterine growth
restriction; preeclampsia and preterm delivery. Furthermore,
epidemiological studies identify a strong association between
compromised placental structure and function, impaired fetal
growth and the development of adult-onset diseases [1–3].
Development of the vascular network within placental villi
during first trimester is a critical process that involves both
vasculogenesis and angiogenesis. In humans, vasculogenesis starts
during the third week post-conception. Hemangioblastic cell cords
differentiate in situ from placental mesenchymal stem cells in the
villous cores. The cords elongate through proliferation and cell
recruitment, and connect with the vasculature of the developing
fetus. A feto-placental circulation starts around 8 weeks of
gestation and perfusion of the placental villi by maternal blood
occurs 4–6 weeks later. Elongation of the capillaries results in
looping of the vessels. Obtrusion of both capillary loops and new
sprouts results in the formation of terminal villi.
The placental vasculature continues to develop and adapt
during pregnancy in response to the increasing requirements of the
fetus. Reynolds et al., [4] reported that the large increase in
transplacental exchange, that supports the exponential increase in
fetal growth during the last half of gestation, depends primarily on
the dramatic growth of the placental vascular beds and the
resultant large increases in uterine and umbilical blood flow [5].
The microvasculature of the placenta develops by the process of
branching angiogensis that increases capillary numbers and
surface densities. In the human placenta, branching angiogenesis,
the formation of new vessels through sprouting, occurs from 5
weeks gestation through to 24 weeks gestation, while non-
branching angiogenesis, the formation of capillary loops through
elongation, predominates thereafter to term.
Available data supports the hypothesis that fetal growth and
energy demand regulates placental growth and vascularization.
For instance, the activity and expression of some nutrient
transporters, in the mouse placenta, is modulated by fetal nutrient
demands for growth [6]. Mutant mouse small placentae are
capable of increasing glucose and amino acid transfer to meet the
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nutrient demands of the growing fetus, particularly in late
gestation [6]. In human trophoblasts, System A, which includes
the amino acid transport genes such as Slc38A1, Slc38A2 and
Slc38A4 has been shown to increase as pregnancy progresses,
coinciding with increased fetal nutrient demands [7]. During late
gestation in rat, glucose transporter genes Slc2A3 and Slc2A1 are
upregulated and downregulated respectively, in placenta [6]. The
molecular and cellular mechanisms that regulate vascularisation
and angiogenesis within the placental villous tree during pregnan-
cy remain to be fully elucidated. Previous studies have established
the utility of rat and mouse models to eluciate the molecular and
cellular mechanisms involved in placentation and placental
development since it is more difficult to obtain human placenta
at various gestational stages [8–10]. Genome-wide gene expression
in rat placenta has been studied in late pregnancy [11] [12]. At
embryonic day 18.5 (E18.5), RNA sequencing showed differential
gene expression between the rat labyrinth zone, junctional zone
and metrial gland [12]. At E21, Buffat et al. reported changes in
genome-wide placental gene expression in rats exposed to an
isocaloric low protein diet [11]. Goyal et al. (2010), studied global
gene expression in placentae from two different rat species at 17.5
days of gestation and found 272 genes differentially expressed [13].
Large scale molecular analysis of the transcriptome of the normal
rat placenta across mid to late gestation, however, has not been
performed. In particular, gestational variation in the expresssion of
genes known to be involved in angiogenesis within the rat placenta
is yet to be documented.
The aim of this study, therefore, was to characterize gestational
variation in rat placental gene expression using microarray
analysis (22,000 gene probes) and specifically identify changes in
the molecular pathways involved in angiogenesis. The hypothesis
to be tested was that genes involved in regulating angiogenesis are
differentially expressed during late gestation compared to late mid-
gestation. Placentae were collected at four gestational ages
(E14.25; E15.25; E17.25 and E20) and gene expression was
compared.
Materials and Methods
Animals and Diets
All animal experiments were performed at the Department of
Anatomy and Developmental Biology, Monash University (Mel-
bourne, Australia) with the approval of The School of Biomedical
Sciences Animal Ethics Committee of Monash University.
Experiments were carried out in accordance with the National
Health and Medical Research Council of Australia ‘‘Australian Code
of Practice for the Care and Use of Animals for Scientific Purposes’’ (7th
edition, 2004).
Sprague Dawley dams were allowed to adapt to the animal house
for one week, consuming standard chow diet and water ad libitum
prior to start of the study. The animals were maintained in a light
controlled environment (12 h light/dark cycle) throughout this
study and fed on a standard chow diet. Animals were time mated
in a 3 hour period, with male Sprague Dawley rats. This was
designated as Day 0 of pregnancy. The rationale of using a 3 h
window mating time is to reduce variability of gestational age
among the offspring and to maximize the accuracy in staging of
gestation. Pregnancy was confirmed at the time of sacrifice. After
mating, dams were housed individually. All animals had access to
food and water ad libitum throughout this study.
Tissue Collection
The pregnant dams were anaesthetized (Isoflurane Rhodia
Australia P/L, VIC, Australia) and sacrificed at embryonic day (E)
14.25, 15.25, 17.25 and 20 (n= 6 per gestational age). Whole
placentae were collected from the pregnant dams, weighed and
then snap frozen in liquid nitrogen. Tissues were stored at 280uC
until processed and analysed.
RNA Isolation
Total RNA was extracted from 30 mg of pulverized frozen
placental tissue (n = 6 placentae per gestational age group, one
placenta per dam), using the AllPrep DNA/RNA Mini Kit
(Qiagen) as per manufacturers’ instructions. Genomic DNA was
removed by On-column Dnase1 treatment. Following extraction,
total RNA was quantified via NanoDrop ND-1000 spectropho-
tometer (Thermo Scientific, DE, USA). RNA quality was verified
using an Agilent 2100 Bioanalyzer (VIC, Australia) prior to the
analysis. RNA samples that fulfilled the following criteria were
selected for microarray analysis: (i) RIN .8.5; (ii) 260/280 ratio
.2; (iii) 260:230.1. RIN (RNA Integrity Number) values were
greater than 8.7. For qPCR, the RNA was reverse transcribed
using the QuantiTect Reverse transcription kit (Qiagen) using
1 mg of RNA per sample.
Microarray Analysis on Illumina Rat Ref Arrays
For the microarray analysis, 500 ng of total RNA was
converted to double stranded cDNA and this was used to
generate biotinylated cRNA probes using the Illumina Total-
Prep RNA Amplification Kit. Biotin-labelled cRNA were then
hybridized to Illumina RatRef-12 Expression BeadChip (San
Diego, CA, USA). Slides were scanned on a BeadStation 500
System using Beadscan software Version 3.5.31. No RNA
samples were pooled in this analysis, each of the placental
samples was analyzed independently. Samples were hybridized
into wells at random. Two chips of 12 wells were used for the
Figure 1. Differentially genes expression during gestation. A)
The total number of differentially expressed genes that were up and
down regulated between the 3 gestational groups i.e. E14.25 vs. E15.25,
E15.25 vs. E17.25 and E17.25 vs. E20 are displayed as fold change (cut-
off.2 and FDR,1%). B) Overall gene expression fold changes from the
earliest time point under study E14.25 right up to E20.
doi:10.1371/journal.pone.0083762.g001
Angiogenic Gene Expression in the Rat Placenta
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e83762
experiment. Illumina Whole-Genome Gene Expression Bead-
Chips consist of oligonucleotides immobilized to beads held in
microwells on the surface of an array substrate. Labelled sample
cRNA were detected by hybridization to 50 mer probes on
BeadChip. Post washing and staining, BeadChips were scanned
on a BeadArray reader. Array experiment readout deposited on
ArrayExpress. ArrayExpress Accession number is E-MTAB-
1987.
Quantitative Real-Time PCR Validation Experiments
qPCR was used to validate the expression of three placental
genes (Ptgs2, Pla2g2a and Nos2) known to display gestational
age changes in expression. Each experiment was performed in
duplicate and normalized against the expression of b-Actin
(Actb) using the ddCt method [14]. RNA was reverse
transcribed into complentary DNA strands, using the Quantitect
Reverse transcription kit (Qiagen, VIC, Australia) following
manufacturers instructions. Primers used for qPCR throughout
the study are detailed in Table S1 and were all designed using
PRIMER-BLAST/ncbi against Rattus Norvegicus mRNA. qPCR
analyses was performed using ABI 6000 using standard SYBR
green from Life Technologies (VIC, Australia). Normalized Ct
ratios were subjected to ANOVA. Spearman’s Rank Correla-
tion, p,0.05 was used for correlation plots. Prior to statistical
analysis of gene expression during gestation, homogeneity of
variance and normality were assessed using Bartlett’s and
Shapiro-Wilk tests, respectively. Normally distributed and
homogenous data were assessed by ANOVA otherwise data
were analysed using non-parametic Kruskal-Wallis tests.
BioInformatic Anayses and Statistics
Bioinformatic analysis was performed by using the Illumina
Beadstudio and Significance Analysis of Microarry (SAM,
Stanford University) software. Data were normalized by perform-
ing a probe-intensity transformation and normalization via the
Lumi package, Bioconductor. After normalization, differentially
expressed placental genes (i.e. .2 fold expression, false discovery
rate of ,1%) were identified using SAM and were further
analysed using Web-based Gene Set Analysis Toolkit (WebGestalt,
http://bioinfo.vanderbilt.edu/webgestalt/). Genes were assigned
to their respective functional classes based on the Gene Ontology
(GO) database. Differences in group means were assessed by post-
hoc comparisons (Bonferroni tests).
Normalized expression data were subjected to Principal
Component Analyses (PCA, XLSTAT). 2D observation plots
were generated for individual gestational age samples and
correlation circles for the 31 angiogenic genes analyzed.
Figure 2. Heat Map of relative expression of Angiogenic genes. Of the 31 differentially expressed genes, 22 were up regulated (A) and 9 were
down regulated (B). The heat map diplays data for 6 individual placentae for each gestational age. The genes correspond to the gene list in Table 1,
where a change from green, black to red indicates and increase in signal. The colour legend above each map shows relative microarray signal ranges
between 0 to 1. Each coloured rectangular box within the heat map represents a separate rat placenta sample. The samples are grouped according to
gestational age i.e. E14.25, E15.25, E17.25, E 20.
doi:10.1371/journal.pone.0083762.g002
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Results
Mircoarray Analysis
To characterize gestational age dependent changes in gene
expression, microarray analysis was performed on placental cDNA
obtained from pregnant rats at gestational days E14.25, E15.25,
E17.25 and E20. A cutoff of .2 fold change in expression and
false discovery rate of less than 1% was used to ascribe the
differential expression of genes. Between gestational age E14.25
and E15.25, 40 gene transcripts were differentially expressed,
between E15.25 vs E17.25, 143 gene transcripts were differentially
expressed and between E17.25 vs E20, 678 were differentially
expressed using SAM Analyses (Figure 1). Specific differentially
expressed angiogenic genes were then selected from the SAM
readout and a heat map (Figure 2) displays expression changes
over time.
Quantitative RT-PCR Validation of Gestational-age
Dependent Genes
qPCR data were consistent with microarray data and estab-
lished that both Ptgs2 and Pla2g2a remain relatively constant
throughout E14.25, E15.25 and E17.25 and increase dramatically
(and also consistent with literature) towards the end of gestation at
E20 (Figure 3). Nos2 on the other hand, is downregulated towards
E17.25 and E20 (Figure 4 and Figure S2).
Classification of Genes Involved in Blood Vessel
Morphogenesis and Angiogenesis
Genes were classsified into pathways using GO (gene ontology)
based upon their Entrez IDs. Within the Blood Vessel Morphogenesis
and Angiogenesis pathway a total of 31 differentially expressed genes
were identified (GO:0048514 : blood vessel morphogenesis [412
gene products] and GO:0001525 : angiogenesis [333 gene
products]). 22 of these genes displayed increased expression and
Figure 3. Comparison of qPCR andmicroarray expression data. qPCR and Microarray data for Ptgs2 are shown in panels A and B respectively;
statistical significance (p values) is presented in panel G. C represents linear correlation between qPCR and microarray data for Ptgs2 (p,0.05). qPCR
and microarray results for Pla2g2a are shown in panels D and E respectively; statistical significance (p values) are presented in panel G. Panel F
indicates the linear correlation (Spearman’s rank correlation) between qPCR and microarray data (p,0.05). Both genes display late gestational
increase. Where * =p,0.05, p,0.0005 = **; p,0.0001 = *** and ns =p.0.05 using one-way ANOVA and post-hoc tests (Bonferroni test).
doi:10.1371/journal.pone.0083762.g003
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9 genes decreased expression across the gestational age groups.
Between E14.25 and E15.25 none of the 31 genes were
differentially expressed, between E15.25 and E17.25, 15 genes
were differentially expressed and between E17.25 and E20, 26
genes were differentially expressed (Table 1, Figure 2, Figure S1
and S2). Figure S4 displays the mean centroid analyses of A)
upregulated and B) downregulated genes.
Quantitative RT-PCR of Angiogenic Genes
The expression of five angiogenic genes (Mmp14, CD36, Angpt4,
Rhob and Foxm1) was confirmed by qPCR (Figure 5). For all genes
examined, a significant correlation between microarray and qPCR
data was established (Spearman’s Rank Correlation, p,0.05).
Principal Component Analysis
PCA of placental angiogenic gene expression separated data
into three distinct groups. E14.25 and E15.25 samples clustered
together, while E17.25 and E20 samples partitioned independently
(with F1 accounting for up to 70% of sample variation, Figure 6).
These data are consistent with the hypothesis that the expression
profile of Blood Vessel Morphogenesis and Angiogenesis genes in the rat
placenta changes significantly after 70% of gestation is reached
and continues to change thoughout the remainder of gestation.
Gestational age based PCA analyses are presented in Figure S3.
Furthermore, PCA indicates that the biological variation within
the gestational age category for these genes is small (n = 6). This
conclusion was additionally supported by ANOVA where the
variance in microarray data was partitioned between, gene
(p,0.00001), gestational age (p,0.00001) and biological replicates
(p.0.9).
Discussion
The aim of this study was to identify mid-late gestation changes
in the expression of genes in the whole rat placenta using
microarray analysis. In particular, this study focused on changes in
genes involved in angiogenic pathways. During mid-late gestation,
fetal demand for energy substrates and gas exchange increases
dramatically in the absence of a concomitant increase in placental
mass. An increase in branching angiogenesis contributes to
placental accommodation during this later gestational period.
The data obtained establish that the expression of approximately
7% of genes profiled (22,000) within the placenta change
significantly between E14.25 and E20 days of gestation. Of this
7%, 42% of genes increased expression and 58% decreased
expression. A subset of 31 genes known to be involved in the Blood
Vessel Morphogenesis pathways were identified, of which ,70%
displayed increased expression with gestational age. RNA
sequencing of different rat placental regions at E18.5 showed that
the blood vessel development pathway was prominent in genes
that were differentially expressed in the labyrinth zone versus the
junctional zone and the metrial gland [12]. In the metrial gland,
the vascular development pathway was enriched [12]. These
results indicate that the vasculature in the rat placenta is
developing late into gestation.
The microarray expression data for eight genes were orthog-
onally validated by qPCR. These genes included three genes
previously known to display gestational age and labour-associated
changes and five genes identified in this study that displayed
altered expression during gestation. Previously, we and others,
have identified late gestation and pre-labour changes in the
expression of enzymes involved in the biosynthesis of eicosanoids
(i.e. prostaglandin synthase 2, Ptgs2 ([15–18] and phospholipase A2
(Pla2a) [19]) and in nitric oxide (i.e. inducible nitric oxide synthase,
Nos2 [20]). Consistent with these observations, the gene expression
of prostaglandin synthase 2 and secretory Pla2a increased (from
Figure 4. Comparison of qPCR and microarray data for Nos2. qPCR and microarray results of Nos2 are presented in panels A and B,
respectively. Statistical significance (p values) is presented in panel D. Panel C depicts linear correlation (Spearman’s rank correlation) between qPCR
and microarray data (p,0.05) Both qPCR and microarray data display a significant decrease in expression with gestational age. (* = p,0.05,
p,0.0005 = **; p,0.0001 = *** and ns =p.0.05).
doi:10.1371/journal.pone.0083762.g004
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E17.25 to E20) and Nos2 decreased (from E15.25 to E20) during
gestation (as determined by both microarray analysis and real-time
PCR). This finding is consistent with current literature. Further-
more, the data for Ptgs2 are consistent with the literature where
expression is known to increase prior to the onset of labour
[10,12,13]). Phospholipases hydrolyze phospholipids into fatty
acids. Phospholipase A2 is an important mediator of arachidonic
acid formation, which are the substrates of eicosanoids such as
prostaglandins. It has been reported that there is a relative
abundance of phospholipase protein in late pregnancy [19].
Of the 31 Blood Vessel Morphogenesis pathway genes that displayed
differental expression during gestation in this study, the expression
of Cd36, Mmp14, Angpt4, Rhob and Foxm1 was confirmed by qPCR
on same samples. In all cases, concordance between microarray
and qPCR data was confirmed. These five genes were chosen on
the basis of their function and the fold changes shown in Table 1.
CD36 is a, cell membrane scavenger receptor involved in
angiogenesis, inflammation and lipid metabolism [21]. In micro-
vascular endothelial cells it functions as a receptor for Thrombos-
pondin-1 (TSP-1) [22]. CD36 has been implicated in inflamma-
tory processes via the activation of phospholipases and the
formation of prostaglandins [23] and the cellular uptake of fatty
acids via the activation of peroxisome proliferator–activated
receptor c [24]. In this study, Cd36 expression increased by 2.8
Table 1. List of Angiogenic genes identified and pairwise comparison of gene expression between gestational age groups.
Gene Identifiers E14.25 vs E15.25 E15.25 vs E17.25 E17.25 vs E20 E14.25 vs E20
Gene name Entrez ID Fold change p value Fold change p value Fold change p value Fold change p value
Up- regulated
22 genes
Bmp4 25296 – ns – ns 3.8 *** 6.77 ***
Vegfa 83785 – ns ,2 * – ns 3.04 ***
Mmp14 81707 – ns ,2 *** – ns 3.44 ***
Acvrl1 25237 – ns 2.8 *** – ns 3.42 ***
Edn1 24323 – ns – ns ,2 *** 3.61 ***
IL18 29197 – ns – ns 6.4 *** 6.74 ***
Gpx1 24404 – ns – ns 3.7 *** 3.69 ***
Id1 25261 – ns – ns ,2 *** 4.27 ***
Cd36 29184 – ns 2.8 *** ,2 *** 4.87 ***
Hs6st1 316325 – ns – ns ,2 *** ,2 ***
Emcn 295490 – ns ,2 ** ,2 *** 2.94 ***
Rhob 64373 – ns – ns ,2 *** 2.31 ***
Prl7d1 84377 – ns – ns ,2 *** 9.29 ***
Angptl4 362850 – ns 3.1 *** 3.7 *** 6.93 ***
Sox18 311723 – ns ,2 ** – ns ,2 ***
Klf5 84410 – ns ,2 * ,2 ** ,2 ***
Pf4 360918 – ns – ns 3.0 *** 2.38 ***
Cav1 25404 – ns 6.7 *** ,2 *** 15.46 ***
Sgpl1 286896 – ns – ns ,2 *** 2.64 ***
Notch4 406162 – ns – ns ,2 *** ,2 ***
Tek 89804 – ns ,2 * 2.2 *** 4.72 ***
Tgm2 56083 – ns ,2 ** ,2 *** 2.34 ***
Down-regulated
9 genes
Itgb2 309684 – ns – ns .0.5 ** .0.5 ***
ItgaV 296456 – ns – ns .0.5 * 0.41 ***
Itga4 311144 – ns .0.5 * 0.4 *** ns ***
Foxm1 58921 – ns .0.5 ** 0.4 *** 0.20 ***
Anpep 81641 – ns – ns 0.2 *** 0.2 ***
Gbx2 114500 – ns – ns 0.2 *** 0.13 ***
Atg5 365601 – ns .0.5 ** – ns .0.5 ***
Cited2 114490 – ns – ns 0.5 *** 0.5 ***
Nos2 24599 – ns .0.5 * 0.2 *** 0.16 ***
E14.25 vs E15.25 - no significant differences in gene expression. E15.25 vs E17.25–15 of 31 genes were differentially expressed. E17.25 vs E20–26 of 31 genes were
differentially expressed. E14.25 vs E20 shows gene expression changes for each gene from E14.25 vs E20. Significance was ascribed where gene expression was changed
by ,2 (* = p,0.05, p,0.0005 = **; p,0.0001 = *** and ns = p.0.05). The order of the genes listed in the table corresponds to the Heat Map on Figure 2.
doi:10.1371/journal.pone.0083762.t001
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fold during E15.25 to E17.25 days of gestation and remains
significantly elevated till labour onset. Interestingly, increased
expression of Cd36 mRNA and protein is observed in cord blood
from late pregnancy compared with early pregnancy samples.
Figure 5. qPCR validation of 5 Angiogenic genes. For Mmp14, qPCR are microarray data are presented in panels A and B, respectively; for Rhob
in panels C and D; for CD36 in panels E and F; for Angpt4 in panels G and H; for Foxm1 in panels I and J. Statistical significance (p values) is presented
in panel K. Where p,0.05 = *; p,0.0005= **; p,0.0001= *** as assessed by one way ANOVA and post-hoc tests (Bonferroni test). The x-axes in all
graphs represent the 4 gestational age groups. Y-axes for qPCR graphs denote relative fold change normalised to b-actin. The y-axes for the
microarray bar charts denote microarray hybridisation signals.
doi:10.1371/journal.pone.0083762.g005
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Mmp14 encodes for MMP14 (EC 3.4.24.80, also known as
MT1-MMP) which is a key extracellular matrix-remodeling
enzyme that promotes collagen remodeling. MMP14 is a
dominant cell-surface protease required for endothelial cell tube
morphogenesis, invasion and for the creation of vascular guidance
tube [23]. However, there is only limited information about the
specific role of MMP14 role in placental angiogenesis. In mouse
placentae, MMP14 is strongly expressed in the labyrinth region
[25]. This region of the placenta is critical for the formation of
syncytiotrophoblast and the subsequent formation of fetal vessels.
In human placentae, immunoreactive MMP14 is expressed in
term and preterm syncytiotrophoblast cells, where it may
contribute to the cleavage and release of endoglin [26] and in
the endothelium of feto-placental vessels. Endoglin has been
suggested to be a major factor in the development of preeclampsia
[27]. Placental expression of MMP14 is greater in pregnancies
complicated by gestational diabetes mellitus [28] and, in vitro it is
induced by insulin and IGF-II in vitro [28] and HIF-1a [24]. In this
study, Mmp14 mRNA expression increased from E15.25 to
E17.25 (the peak of trophoblast invasion takes place at this stage)
[29]. Another gene that is involved in prostaglandin regulation is
Sgpl1 (SGPL1, EC 4.1.2.27) which catalizes the irreversible
degradation of the sphingosine-1-phosphate (S1P) [30]. S1P is a
bioactive lipid mediator that promotes cell proliferation, survival,
migration, adherence, inflammation and angiogenesis [31].
SGPL1, thus, regulates the available pool of S1P and inhibits its
signalling activities. SGPL1 may regulate S1P-induced Ptgs2
expression in the rat myometrium [32]. In this study, Sgpl1
expression increased 2.6 fold during gestation from E14.25 to E20.
Angiopoeitin like Protein 4 (EC 2.6.1.2) expression was low at
E14.25 and E15.25 and increases at E17.25 remaining constant till
E20. Over the gestational period assessed in this study, Angpt4 gene
expression increased,7-fold. Angpt4, like the other angiopoietins 1
and 2 has been reported to play a role in angiogenesis [33].
Yamakawa et al., reported that ANGPT4 increased endothelial
cell migration and tube formation in vitro and reduced vascular
leakage [34]. Angiogenic effects of ANGPT4 have also been
observed in glioblastoma [35]. To date little is known about the
biological functions of ANGPT4 in the placenta. However,
ANGPT1 has been shown to potentiate VEGF activity and work
together to increase the luminal diameter of blood vessels in sheep
placenta [36]. In this study, the receptor for ANGPT1, ANGPT2
[36] and ANGPT4, TEK (Tek) showed an increase in placental
expression during from E15.25 to E17.25 and further from E17.25
to E20 (fold change 2.2) of gestation. TEK has been implicated in
the regulation of angiogenesis and cell proliferation, migration and
survival [36]. Tek expression was significantly, positively correlated
(p,0.05) with Angpt4 expression during gestation, (upregulated
prior to labour) indicating the possibility that they are working
together to promote late gestational angiogenesis. TIE 1 is the
other receptor for ANGPT4 and in our Microarray study,
interestingly, Tie1 expression does not change from E14.25 right
up to E20 (Data not shown).
Ras homolog family member B, Rhob has not been extensively
studied in the placenta. The data obtained in this study (both
Figure 6. Principal Component Analysis (PCA). Principal components F1 vs. F2 for individual gestational age groups (n = 6, E14.25, E15.25,
E17.25 and E20) for all 31 angiogenic genes are plotted to identify variation in gene expression. Day E14.25 and E15.25 samples cluster together,
indicating a similar genes expression profile between these 2 groups. Samples within the E17.25 and E20 groups, however, display independent
clustering, indicative of significantly altered gene expression profiles. Biological replicates within each gestational age group are tightly clustered.
doi:10.1371/journal.pone.0083762.g006
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microarray and qPCR) establish that Rhob expression gradually
increases during gestation (from E14.25 to E20), by a fold change
of 2.3. Recently, RHOB (EC 3.6.1.47) was shown to regulate
endothelial cell migration, sprouting, and capillary morphogenesis
[37], although the mechanism by which RHOB regulates
angiogenesis is not well understood. Howe and Addison (2012)
concluded that RHOB plays a significant role in VEGF-induced
endothelial cell morphogenesis, in part, by negatively modulating
the activity of RHOA, [37]. Both RHOA (Ras homolog family
member A) and RHOB are essential downstream effectors of
VEGF signalling in the angiogenic process. siRNA-inhibition of
RhoB results in increased RHOA activation in response to VEGF
(vascular edothelial growth factor) stimulation [37]. Vegf was also
seen to upregulate the expression of RhoB [26]. In our study, we
see that both RhoB and Vegf are up regulated towards late gestation,
first Vegf expression increases at E15.25 and then Rhob expression
increases downstream at E17.25, indicating a positive correlation.
Placental expression of Vegfa was increased 3-fold between E14.25
and E20 in the present study. VEGF is known to be an important
regulator of angiogenesis in placenta [38], [39] and its increased
expression during late gestation has been previously reported [5],
while its receptor Flk (i.e VegfR2) is downregulated from E14.25 vs
E20, prior to labour (Microarray data not shown).NOTCH-4 is a
modulator of angiogenesis in human placenta and regulates
placental cell fate [40–42]. Similar to RHOB expression, Notch
signalling acts downstream of VEGF. Notch signalling helps to
regulate endothelial cell morphogenesis via activation of MMPs
[43]. In this study, Notch-4 expression doubled between E15.25
and E20, where its expression is elevated prior to term/labour.
The transcriptional regulator Foxheadbox M1 (Foxm1) was
expressed during late midgestation (E14.25–E15.25, as assessed by
both microarray and qPCR) but decreased 5-fold by E20. Little,
however, is known about FOXM1 function in angiogenesis in the
placenta. Interestingly, the onset of labour in humans is associated
with decreased placental expression of Foxheadbox O4, (both
FoxO4 mRNA and protein) where it may function as a negative
regulator of Ptgs2 expression and prostaglandin biosynthesis [44].
In cancer development and progression, FOXM1 has been
implicated in regulating the expression of the human endothelial
cell caveolae-marker CAV-1 and Foxm1 expression has also been
linked to growth of glioma cells in tumour angiogenesis [45,46].
Placental Cav-1 mRNA expression increased during gestation in
this study. Caveolin has been reported to facilitate VEGF/NO-
mediated angiogenesis [47]. Our data show, Cav-1 expression
increased 6.7 fold between E15.25 and E17.25 and further
increased till E20. CAV-1 is known to interact with FGFR1which
modulates FGF2 related placental angiogenesis [48]. Unlike in
cancer progression we show that an increase in Cav-1 and Vegf
expression is negatively correlated with Foxm1 expression. An
increase in FOXM1 could have a negative effect on CAV-1
expression or its expression is perhaps acutely switched off prior to
labour onset. Figure S5 shows CAV-1 protein localised intensively
around placental blood vessels indicating its important role in
Angiogenesis.
Angiogenic genes of significance that were upregulated (based
on microarray data alone) during gestation included: bone
morphogenetic protein 4 (Bmp4); transglutaminase (Tgm EC
2.3.2.13); sphingosine-1 phosphate lyase (Sgpl1, EC 4.1.2.27);
endomucin (Emcn); Interleukin-18 (IL-18) and glutathione perox-
idase 1 (Gpx1, EC 1.11.1.9).
Microarray analysis also identifed a suite of Blood Vessel
Morphogenesis pathway genes that were downregulated during late
gestation, prior to labor onset. These included, Itga4, Itgb2, Anpep
and Cited2. The integrin subunits alpha 4 (Itga4) and beta 2 (Itgb2)
have been previously identified in placentae [26,28] [49]. ITGA4
forms a heterodimer with integrin beta 1 to function as a receptor
for collagen. Increased expression of ITGA4 has been implicated
in inhibition of endothelial cell migation during angiogeneis [49].
In this study, Itga4 gene expression decreases during gestation
(from E15.25 right up to E20) and Itgb2 expression decreases
acutely prior to labour onset. Cited2 gene expression also decreases
during late gestation from E17.25 to E20 by two fold. In the mouse
placenta, lack of CITED2 is characterized by disorganization of
the placental fetal vasculature and a fewer trophoblast giant cells,
spongiotrophoblasts and glycogen cells [50]. Hence Cited2 is
important for normal placental vascularisation.
Additionaly, during late gestation in rat, glucose transporter
genes Slc2A3 and Slc2A1 are upregulated and downregulated
respectively, in placenta [6]. This is consistent with our microarray
data where Slc2A3 expression increases from E15.25 to E17.25
and further increases at E20 and Slc2A1 is increased from E15.25
to E17.25 and then gets downregulated at E20 (data not shown).
Amino acid transport genes such as Slc38A1, Slc38A2 and Slc38A4
have been shown to increase with gestation, coinciding with
increased fetal nutrient demands [7], which is also consistent with
our microarray data. We can relate the Angiogenic expression
changes in this study to the expression of several transporter genes.
In conclusion, the data obtained in this study extends our
understanding of placental genes that may contribute to placental
vascular accommodation during mid-late gestation and late-
gestation, in particular, those involved in regulating placental
angiogenesis. Several of these gene products work together either
directly or indirectly. However, we are not able to ascertain that
the pre labour associated changes seen in these 32 angiogenic
genes, has any link with the actual labour process, even though
some of the changes are acute. Further studies need to be carried
out to prove a link between some or all of these genes with the
onset or trigger of labour. The study identified gestational age-
dependent changes in placental gene expression within the Blood
Vessel Morphogenesis pathways that have not previously been
characterized in rat placenta. Furthermore, it confirms and
extends data for genes previously reported to display gestational
and potential labor-associated changes. We also observed that,
most expression changes for these genes, occurred between E17.25
and E20, prior to labour onset. One caveat that must be
considered in interpreting the results obtained in this study is that
mRNA was extracted from whole placental tissue. Therefore, it is
not possible to attribute observed changes in gene expression to
specific cell types that comprise the rat placenta. Nevertheless, the
data obtained identify lead candidate genes for subsequent cell
specific analyses (e.g. based cell selection using laser capture
microscopy) and provide opportunity to further elucidate func-
tional pathways that may be of significance in mid-late placental
function in both normal and pathological pregnancies.
Supporting Information
Figure S1 Gestational Variation in Angiogenic gene
expression of 22 genes that display a late gestational
increase. The x-axis indicates the gestational ages whereas the y-
axis indicates the signal obtained from the microarray hybridisa-
tion using the Illumina Bead reader. These 22 genes had SAM p
values ,0.0001.
(TIF)
Figure S2 Gestational Variation in Angiogenic gene
expression of 9 genes that display a late gestational
decrease. The x-axis indicates the gestational ages in days
whereas the y-axis indicates the signal obtained from the
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microarray hybridisation using the Illumina Bead reader. SAM p
values were ,0.0001.
(TIF)
Figure S3 Two Dimensional PCA Observational plots
for Gestational Age Comparison Groups: A) E14.25 vs.
E15.25. PCA plot F1 vs. F2. B) E15.25 vs. E17.25. PCA plot F1 vs.
F2. C) E17.25 vs E20. PCA plot F1 vs. F2. Data were analyzed
using Pearson Correlation Matrix (XLSTAT, p,0.05).
(TIF)
Figure S4 Mean Centroid of Angiogenesis. A) for upregu-
lated genes B) for down regulated genes using Kruskal-Wallist test
of Mean Centroid. A)E20 vs E14.25= ***, E20 vs E15.25= ***
and E20 vs E17.25= ns and B)E20 vs E14.25= *, E20 vs
E15.25= *** and E20 vs E17.25= ns. (* = p,0.05,
p,0.0005= **; p,0.0001= *** and ns = p.0.05).
(TIF)
Figure S5 Immunohistochemical Localization of CAV-1
and BMP4. Intense staining for CAV-1 around placental blood
vessels (A and B), BMP4 (C and D) in endothelial cells lining blood
vessels and Rabbit IgG Isotype Negative Control (E). Haemotox-
ylin staining of nuclei shown in blue.
(TIF)
Table S1 List of Primer oligonucleotide sequences used
for qPCR experiments.
(TIF)
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